Leerink Report: About 900 Next-Gen Sequencers Deployed to Date; Market Poised for Growth

The reports note that Illumina's Genome Analyzer currently accounts for about two-thirds of next-gen sequencing systems housed at 15 international genome centers, though smaller labs tend to have a "far more equitable" split between Illumina's GA, Applied Biosystems' SOLiD, and 454 Life Sciences's GS FLX.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.